These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3966545

  • 1. Regulation of plasma lipid levels by plasma viscosity in nephrotic rats.
    Yedgar S, Eilam O, Shafrir E.
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E10-4. PubMed ID: 3966545
    [Abstract] [Full Text] [Related]

  • 2. High density lipoproteinuria in nephrotic syndrome.
    de Mendoza SG, Kashyap ML, Chen CY, Lutmer RF.
    Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E, Calandra S.
    Biochim Biophys Acta; 1982 Feb 15; 710(2):188-96. PubMed ID: 7066357
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M, Taş S, Sarandöl E, Tokullugil HA.
    Kobe J Med Sci; 1998 Dec 15; 44(5-6):235-45. PubMed ID: 10401226
    [Abstract] [Full Text] [Related]

  • 6. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E.
    Isr J Med Sci; 1996 Jun 15; 32(6):390-7. PubMed ID: 8682644
    [Abstract] [Full Text] [Related]

  • 7. Viscosity regulates apolipoprotein A-1 gene expression in experimental models of secondary hyperlipidemia and in cultured hepatocytes.
    Nuño P, Hernández A, Mendoza-Figueroa T, Panduro A.
    Biochim Biophys Acta; 1997 Feb 18; 1344(3):262-9. PubMed ID: 9059516
    [Abstract] [Full Text] [Related]

  • 8. Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin.
    Calandra S, Tarugi P, Ghisellini M, Gherardi E.
    Exp Mol Pathol; 1983 Dec 18; 39(3):282-99. PubMed ID: 6416889
    [Abstract] [Full Text] [Related]

  • 9. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.
    McKenzie IF, Nestel PJ.
    J Clin Invest; 1968 Jul 18; 47(7):1685-95. PubMed ID: 5658595
    [Abstract] [Full Text] [Related]

  • 10. Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome.
    Joven J, Masana L, Villabona C, Vilella E, Bargalló T, Trias M, Figueras M, Turner PR.
    Metabolism; 1989 May 18; 38(5):491-5. PubMed ID: 2725289
    [Abstract] [Full Text] [Related]

  • 11. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.
    al-Shurbaji A, Berglund L, Berge RK, Cederblad G, Humble E.
    Lipids; 1997 Aug 18; 32(8):847-52. PubMed ID: 9270976
    [Abstract] [Full Text] [Related]

  • 12. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep 18; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 13. Studies on abnormal lipid metabolism in experimental nephrotic syndrome.
    Agbedana ED, Yamamoto T, Moriwaki Y, Suda M, Takahashi S, Higashino K.
    Nephron; 1993 Sep 18; 64(2):256-61. PubMed ID: 8321360
    [Abstract] [Full Text] [Related]

  • 14. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
    al-Shurbaji A, Skorve J, Berge RK, Rudling M, Björkhem I, Berglund L.
    Arterioscler Thromb; 1993 Nov 18; 13(11):1580-6. PubMed ID: 8218098
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T, Morohoshi T.
    Nephron; 1992 Nov 18; 60(4):443-7. PubMed ID: 1584321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA.
    Miner Electrolyte Metab; 1992 Nov 18; 18(2-5):212-6. PubMed ID: 1465061
    [Abstract] [Full Text] [Related]

  • 19. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND, Liang KH.
    Circulation; 2004 Jul 27; 110(4):419-25. PubMed ID: 15262831
    [Abstract] [Full Text] [Related]

  • 20. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW, Gottlieb BA, Marsh JB, Sparks CE.
    J Clin Invest; 1984 Oct 27; 74(4):1375-83. PubMed ID: 6480830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.